deoxyglucose has been researched along with Metabolic Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Landa-Galvan, HV; Olivares-Reyes, JA; Rios-Castro, E; Romero-Garcia, T; Rueda, A | 1 |
| Blangero, J; Bozaoglu, K; Cameron-Smith, D; Carless, MA; Collier, GR; Curran, JE; Dyer, TD; Foletta, VC; Jowett, JB; Konstantopoulos, N; McAinch, AJ; Moses, EK; Prior, MJ; Segal, DH; Walder, KR | 1 |
| Cai, W; Chen, X; Ramdas, M; Striker, GE; Vlassara, H; Zhu, L | 1 |
| Adachi, I; Ishikawa, F; Kato, A; Kunimatsu, T; Takeshita, K; Yamashita, Y | 1 |
| Freedman, BD; Jameson, JL; Lee, EJ; Park, Y | 1 |
| Proctor, SD; Russell, JC | 1 |
6 other study(ies) available for deoxyglucose and Metabolic Syndrome
| Article | Year |
|---|---|
Metabolic syndrome diminishes insulin-induced Akt activation and causes a redistribution of Akt-interacting proteins in cardiomyocytes.
Topics: Animals; Caveolin 3; Deoxyglucose; Enzyme Activation; Glucose Tolerance Test; Insulin; Male; Metabolic Syndrome; Myocytes, Cardiac; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-akt; Rats, Wistar; Reproducibility of Results | 2020 |
The characterization of Abelson helper integration site-1 in skeletal muscle and its links to the metabolic syndrome.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Blood Glucose; Blotting, Western; Body Weight; Cells, Cultured; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Genotype; Glucose; Humans; Insulin; Insulin Resistance; Metabolic Syndrome; Mexican Americans; Muscle Fibers, Skeletal; Muscle, Skeletal; Myoblasts; Obesity; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection | 2010 |
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.
Topics: 3T3-L1 Cells; Adipocytes; Administration, Oral; Animals; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Humans; Inflammation; Insulin Receptor Substrate Proteins; Macrophages; Metabolic Syndrome; Mice; Oxidative Stress; Proto-Oncogene Proteins c-akt; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Sirtuin 1 | 2012 |
Protective effects of dietary 1,5-anhydro-D-glucitol as a blood glucose regulator in diabetes and metabolic syndrome.
Topics: Administration, Oral; alpha-Glucosidases; Animals; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glycoside Hydrolase Inhibitors; Glycosuria; Hyperglycemia; Intestines; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL | 2013 |
A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome.
Topics: Adipocytes; Alleles; Animal Feed; Animals; Binding Sites; Blood Pressure; Blotting, Southern; Calorimetry; Crosses, Genetic; Culture Media, Serum-Free; Deoxyglucose; Disease Models, Animal; DNA Primers; Drug Resistance; Exons; Fatty Acids; Fatty Liver; Female; Genes, Dominant; Glucose; Heterozygote; Homozygote; Humans; Immunohistochemistry; Insulin; Liver; Male; Metabolic Syndrome; Mice; Mice, Knockout; Mice, Transgenic; Models, Genetic; Muscle, Skeletal; Mutation; Oxygen Consumption; Patch-Clamp Techniques; Phenotype; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2005 |
Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats.
Topics: Acetylcholine; Adiponectin; Animals; Blood Glucose; Body Weight; Deoxyglucose; Dose-Response Relationship, Drug; Eating; Female; In Vitro Techniques; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Nitroprusside; Obesity; Phenylephrine; Rats; Rats, Inbred Strains; Rats, Mutant Strains; Renal Circulation; Time Factors; Vascular Diseases; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2007 |